Clinical studies with individuals bearing recessive mutations in SLCO2A1 have demonstrated that SLCO2A1 is a causative gene for primary hypertrophic osteoarthropathy (PHO) and CEAS, in which PGE2 catabolism is defective [1, 9]. Here, SLCO2A1 is linked to primary hypertrophic osteoarthropathy.